[go: up one dir, main page]

EA200800774A1 - Стабильная твёрдая композиция сертиндола - Google Patents

Стабильная твёрдая композиция сертиндола

Info

Publication number
EA200800774A1
EA200800774A1 EA200800774A EA200800774A EA200800774A1 EA 200800774 A1 EA200800774 A1 EA 200800774A1 EA 200800774 A EA200800774 A EA 200800774A EA 200800774 A EA200800774 A EA 200800774A EA 200800774 A1 EA200800774 A1 EA 200800774A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sertindol
composition
stable firm
sertindole
pharmaceutical composition
Prior art date
Application number
EA200800774A
Other languages
English (en)
Other versions
EA013167B1 (ru
Inventor
Флемминг Энок Ольсен
Анна Равнхолт Кристенсен
Кен Лильегрен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200800774A1 publication Critical patent/EA200800774A1/ru
Publication of EA013167B1 publication Critical patent/EA013167B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к фармацевтической композиции, содержащей сертиндол и защитное вещество, поглощающее излучение с длиной волны меньше 400 нм. Настоящее изобретение также относится к применению сертиндола для получения фармацевтической композиции, содержащей сертиндол и слой покрытия, содержащий указанное защитное вещество, такое как окись железа, для лечения шизофрении.
EA200800774A 2005-09-08 2006-09-06 Стабильная твёрдая композиция сертиндола EA013167B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200501255 2005-09-08
PCT/DK2006/050038 WO2007065448A1 (en) 2005-09-08 2006-09-06 Stable solid formulation of sertindole

Publications (2)

Publication Number Publication Date
EA200800774A1 true EA200800774A1 (ru) 2008-06-30
EA013167B1 EA013167B1 (ru) 2010-02-26

Family

ID=37697999

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800774A EA013167B1 (ru) 2005-09-08 2006-09-06 Стабильная твёрдая композиция сертиндола

Country Status (17)

Country Link
EP (1) EP1924261A1 (ru)
JP (1) JP2009507051A (ru)
KR (1) KR20080042102A (ru)
CN (1) CN101257906A (ru)
AR (1) AR056475A1 (ru)
AU (1) AU2006322460A1 (ru)
BR (1) BRPI0615630A2 (ru)
CA (1) CA2621866A1 (ru)
EA (1) EA013167B1 (ru)
IL (1) IL189541A0 (ru)
MX (1) MX2008002290A (ru)
NO (1) NO20081721L (ru)
NZ (1) NZ565330A (ru)
TW (1) TW200738239A (ru)
UA (1) UA97349C2 (ru)
WO (1) WO2007065448A1 (ru)
ZA (1) ZA200801169B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
JP5591128B2 (ja) * 2009-01-29 2014-09-17 大日本住友製薬株式会社 内核を有する口腔内崩壊錠
FR2943061B1 (fr) * 2009-03-13 2011-02-25 Rhodia Operations Composes organophosphores, systemes catalytiques comprenant ces composes et procede d'hydrocyanation ou d'hydroformylation utilisant ces systemes catalytiques
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
CN104684897A (zh) 2012-07-16 2015-06-03 菲布罗根有限公司 脯氨酰羟化酶抑制剂的晶体形态
SMT202000190T1 (it) 2013-06-06 2020-05-08 Fibrogen Inc Formulazioni farmaceutiche di un inibitore di hif-idrossilasi
CN105636585B (zh) 2013-11-19 2020-02-07 西佳技术公司 微粉化特考韦瑞一水化物的再水化
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
AU2587297A (en) * 1996-03-25 1997-10-17 Eli Lilly And Company Method for treating pain
ZA973433B (en) * 1996-04-24 1997-12-10 Shionogi & Co A sertindole-containing preparation and a method for producing the same.
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
TW200738239A (en) 2007-10-16
CA2621866A1 (en) 2007-06-14
KR20080042102A (ko) 2008-05-14
UA97349C2 (ru) 2012-02-10
NO20081721L (no) 2008-04-08
WO2007065448A1 (en) 2007-06-14
ZA200801169B (en) 2010-07-28
EP1924261A1 (en) 2008-05-28
JP2009507051A (ja) 2009-02-19
AR056475A1 (es) 2007-10-10
AU2006322460A1 (en) 2007-06-14
CN101257906A (zh) 2008-09-03
IL189541A0 (en) 2008-08-07
MX2008002290A (es) 2008-03-14
EA013167B1 (ru) 2010-02-26
NZ565330A (en) 2011-06-30
BRPI0615630A2 (pt) 2016-11-16

Similar Documents

Publication Publication Date Title
EA200800774A1 (ru) Стабильная твёрдая композиция сертиндола
NO20074044L (no) Meleimidderivater, farmasoytiske preparater og fremgangsmater for behandling av kreft
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
WO2008097640A3 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
UA107783C2 (en) Isoindoline compounds for use in treating cancer
DK1951729T3 (da) Oxygenbundne pyrimidinderivater
UY29246A1 (es) Nuevos compuestos
BRPI0915084B8 (pt) composto, e, composição farmacêutica
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
CL2008003593A1 (es) Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
JO2578B1 (en) Compounds Theophene benzimidazole
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
TW200738659A (en) Novel compounds
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
CL2008000021A1 (es) Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer.
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
CL2008003472A1 (es) Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias.
EA201170344A1 (ru) Азаиндольные ингибиторы iap
BR0313220A (pt) Pelìcula de revestimento para comprimidos e cápsulas
CL2008001990A1 (es) Compuestos derivados de amino-quinazolinas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de alzheimer.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM